Search research articles
Contact Us
Filters
Showing results (351-360 of 397) with videos related to
Page
of 40
Sort By:
Journal of Immunotherapy and Precision Oncology
|
February 17, 2025
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial
Mirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
Cancer Medicine
|
February 13, 2025
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma
Omar Alhalabi, Mohamed A Gouda, Denái R Milton, et al.
Frontiers in Immunology
|
February 8, 2021
Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications
Sang T Kim, Ajay Sheshadri, Vickie Shannon, et al.
Molecular Cancer Research : MCR
|
December 16, 2020
Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, et al.
Journal for Immunotherapy of Cancer
|
October 24, 2020
Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory
Tito Mendoza, Ajay Sheshadri, Mehmet Altan, et al.
Journal for Immunotherapy of Cancer
|
June 24, 2026
Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors
Mohamed H Derbala, Bettzy Stephen, Woochan Hwang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 17, 2016
Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors
Aung Naing, Kyriakos P Papadopoulos, Karen A Autio, et al.
NPJ Precision Oncology
|
October 27, 2022
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology
Henry Hiep Vo, Siqing Fu, David S Hong, et al.
Cancer
|
July 6, 2022
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study
Vinod Ravi, Aparna Subramaniam, Jing Zheng, et al.
Oncotarget
|
May 19, 2015
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
Filip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Page
of 40
Search research articles
Search
Showing results (351-360 of 397) with videos related to
Sort By:
Page
of 40
Journal of Immunotherapy and Precision Oncology
|
February 17, 2025
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial
Mirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
Cancer Medicine
|
February 13, 2025
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma
Omar Alhalabi, Mohamed A Gouda, Denái R Milton, et al.
Frontiers in Immunology
|
February 8, 2021
Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications
Sang T Kim, Ajay Sheshadri, Vickie Shannon, et al.
Molecular Cancer Research : MCR
|
December 16, 2020
Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, et al.
Journal for Immunotherapy of Cancer
|
October 24, 2020
Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory
Tito Mendoza, Ajay Sheshadri, Mehmet Altan, et al.
Journal for Immunotherapy of Cancer
|
June 24, 2026
Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors
Mohamed H Derbala, Bettzy Stephen, Woochan Hwang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 17, 2016
Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors
Aung Naing, Kyriakos P Papadopoulos, Karen A Autio, et al.
NPJ Precision Oncology
|
October 27, 2022
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology
Henry Hiep Vo, Siqing Fu, David S Hong, et al.
Cancer
|
July 6, 2022
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study
Vinod Ravi, Aparna Subramaniam, Jing Zheng, et al.
Oncotarget
|
May 19, 2015
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
Filip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Page
of 40